Helix Healthcare Group

helixhealthcaregroup.com

Helix Healthcare Group is an innovative provider of treatment services for those facing mental health, trauma and/or addiction issues. As the first of its kind in Canada, the boutique treatment facility offers a unique, holistic approach that pairs traditional methods of care with cutting-edge therapies to help clients achieve lasting change.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

GSK COLLABORATES WITH VIR BIOTECHNOLOGY TO FIND CORONAVIRUS SOLUTIONS

HospiMedica International | April 07, 2020

news image

GlaxoSmithKline plc (London, UK) and Vir Biotechnology, Inc. (San Francisco, CA, USA) have entered into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. The collaboration will use Vir’s proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies that could be used as therapeutic or preventative options to help address the current COVID-19 pandemic and future outbr...

Read More

Industrial Impact

CANOPY BIOSCIENCES LAUNCHES NEXT-GENERATION CHIPCYTOMETRY™ INSTRUMENT FOR SPATIAL BIOLOGY WITH SUB-CELLULAR RESOLUTION

Canopy Biosciences | March 04, 2022

news image

Canopy Biosciences, a Bruker Company, announced the commercial launch of the CellScapeTM system, the next generation in ChipCytometryTM instrumentation, advancing the cutting-edge for quantitative in situ spatial phenotyping. ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue analysis of the tumor microenvironment, as well as deep immune profiling for applications in immunology, neuroscience, and infectious disease. The new benchtop CellScape s...

Read More

Research

BIGHAT BIOSCIENCES COMPLETES FIRST STAGE OF RESEARCH COLLABORATION WITH AMGEN

BigHat Biosciences, Inc. | January 12, 2022

news image

BigHat Biosciences, Inc., a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform, announced the successful completion of the first stage of a previously undisclosed research collaboration and licensing agreement with Amgen applying BigHat’s platform for multi-objective optimization of a next-generation antibody. BigHat’s antibody design platform integrates a high-speed characterization with AI/ML tech...

Read More

ROCHE LAUNCHES EXOME AND CUSTOM KAPA TARGET ENRICHMENT PORTFOLIO TO EMPOWER CLINICAL RESEARCHERS

Roche | May 13, 2020

news image

KAPA HyperExome is a state-of-the-art whole exome research panel with improved performance over the on-market SeqCap portfolio, providing improved coverage and uniformity. The KAPA Target Enrichment portfolio empowers clinical researchers to process more sa...

Read More
news image

GSK COLLABORATES WITH VIR BIOTECHNOLOGY TO FIND CORONAVIRUS SOLUTIONS

HospiMedica International | April 07, 2020

GlaxoSmithKline plc (London, UK) and Vir Biotechnology, Inc. (San Francisco, CA, USA) have entered into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. The collaboration will use Vir’s proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies that could be used as therapeutic or preventative options to help address the current COVID-19 pandemic and future outbr...

Read More
news image

Industrial Impact

CANOPY BIOSCIENCES LAUNCHES NEXT-GENERATION CHIPCYTOMETRY™ INSTRUMENT FOR SPATIAL BIOLOGY WITH SUB-CELLULAR RESOLUTION

Canopy Biosciences | March 04, 2022

Canopy Biosciences, a Bruker Company, announced the commercial launch of the CellScapeTM system, the next generation in ChipCytometryTM instrumentation, advancing the cutting-edge for quantitative in situ spatial phenotyping. ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue analysis of the tumor microenvironment, as well as deep immune profiling for applications in immunology, neuroscience, and infectious disease. The new benchtop CellScape s...

Read More
news image

Research

BIGHAT BIOSCIENCES COMPLETES FIRST STAGE OF RESEARCH COLLABORATION WITH AMGEN

BigHat Biosciences, Inc. | January 12, 2022

BigHat Biosciences, Inc., a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform, announced the successful completion of the first stage of a previously undisclosed research collaboration and licensing agreement with Amgen applying BigHat’s platform for multi-objective optimization of a next-generation antibody. BigHat’s antibody design platform integrates a high-speed characterization with AI/ML tech...

Read More
news image

ROCHE LAUNCHES EXOME AND CUSTOM KAPA TARGET ENRICHMENT PORTFOLIO TO EMPOWER CLINICAL RESEARCHERS

Roche | May 13, 2020

KAPA HyperExome is a state-of-the-art whole exome research panel with improved performance over the on-market SeqCap portfolio, providing improved coverage and uniformity. The KAPA Target Enrichment portfolio empowers clinical researchers to process more sa...

Read More

Resources

resource image

Cell and Gene Therapy

What is Population Genomics?

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us